drugset / Trial / NCT02748525

Evaluation of Gallbladder Contractility Using Both CCK and Milk Consecutively

NCT02748525 ↗

NaSingle-groupOpen-labelDiagnostic

Summary

This study aims to combine the use of IV CCK administration followed by oral milk during a HIDA scan to further stimulate the gallbladder contractility and decrease the number of false abnormal HIDA scans and unnecessary cholecystectomies in some patients.

Timeline

Start
2016-05-03
Primary completion
2018-06-14
Completion
2018-06-14

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background CCK Peptide 0.02 mg/kg Intravenous

Indications

No indication recorded.